A Case of Long-Term Survival after Checkpoint Inhibitor Pneumonitis in a Patient with Squamous Cell Lung Cancer

Figure 1

Changes in chest X-ray images. Before treatment with nivolumab (a), at the onset of CIP (b), 1 week after the onset of CIP (c), 2 weeks after the onset of CIP (d), 1 month after the onset of CIP (e), 2 months after the onset of CIP (f), 3 months after the onset of CIP (g), and 6 months after the onset of CIP (h). The relapsed lung tumor is indicated by the arrows. CIP: checkpoint inhibitor pneumonitis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)